Gasdermin E: A Prospective Target for Therapy of Diseases

Abstract excerpt

Gasdermin E (GSDME) is a member of the gasdermin protein family, which mediates programmed cell death including apoptosis and pyroptosis. Recently, it was suggested that GSDME is activated by chemotherapeutic drugs to stimulate pyroptosis of cancer cells and trigger anti-tumor immunity, which is identified as a tumor suppressor. However, GSDME-mediated pyroptosis contributes to normal tissue damage, leading to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gout, Hyperuricemia, Uric Acid
• Share to Heme Oxygenase-1 and Carbon Monoxide
• Share to Inflammasome and immune disorders